1. Clinical-Risk Factors that Influence an Optimal Hypomethylating Agents Treatment in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia. (April 2017) Authors: Iastrebner, M.; Lazzarino, C.; Nucifora, E.; Penchasky, D.; Fernandez, I.; Gusmao Moreno, B.G.M.; Rivas, M.M.; Espinosa, D.; Abello Polo, V.; Boada, M.; Enrico, A.; Araujo Schuster, S.; Agra, M.; Sarmiento, M.; Flores, G.; Alfonso, G.; Crisp, R.; Gusmao Moreno, B.; Consortium, I. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results. Issue 5 (20th November 2017) Authors: Moreno–Grau, Sonia; Rodríguez‐Gómez, Octavio; Sanabria, Ángela; Pérez‐Cordón, Alba; Sánchez‐Ruiz, Domingo; Abdelnour, Carla; Valero, Sergi; Hernández, Isabel; Rosende‐Roca, Maitée; Mauleón, Ana; Vargas, Liliana; Lafuente, Asunción; Gil, Silvia; Santos‐Santos, Miguel Ángel; Alegret, Montserrat; Es... Journal: Alzheimer's & dementia Issue: Volume 14:Issue 5(2018) Page Start: 634 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Flow Cytometry "Ogata Score" in Latin America. On Behalf of the Grupo Latinoamericano De Mielodisplasia (GLAM). (April 2017) Authors: Grille, S.; Brugnini, A.; Velloso DRP, E.; Cismondi, V.; Jensen, E.; Bacal, N.S.; Solari, L.; Novoa, V.; Boada, M.; Crisp, R.; Rojas S, R.; Fanessi, V.; Gonzalez, J.; Cosentino, R.; Rodriguez, M.; Venegas, B.; Trías, N.; Guevara, R.; Enrico, A.; Lens, D. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗